Jpmorgan Chase & Co »

Nuvectis Pharma shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Nuvectis Pharma (NVCT) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Nuvectis Pharma

Tip: Access up to 7 years of quarterly data

All positions including Nuvectis Pharma held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nuvectis Pharma by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $41k 4.9k 8.34
2023-09-30 $63k 4.9k 12.89
2023-06-30 $87k 5.5k 15.97